awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43580379-7D66B96F-457E-4F1A-90A7-04649A15DE54
Q43580379-7D66B96F-457E-4F1A-90A7-04649A15DE54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43580379-7D66B96F-457E-4F1A-90A7-04649A15DE54
Antiangiogenesis therapy in second line metastatic colorectal cancer: similar but different.
P2860
Q43580379-7D66B96F-457E-4F1A-90A7-04649A15DE54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43580379-7D66B96F-457E-4F1A-90A7-04649A15DE54
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3aea80c814ad2060b3411c33fc176ddd1d7758a
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.